导管原位癌更名：去除“癌”字会减少过度治疗吗？ - Suppr | 超能文献

Renaming ductal carcinoma in situ: would removing "carcinoma" reduce overtreatment?

作者信息

Javid Sara H, Fang L Christine, Korde Larissa, Anderson Benjamin O

出版信息

J Natl Compr Canc Netw. 2014 Apr;12(4):599-602. doi: 10.6004/jnccn.2014.0060.

DOI:10.6004/jnccn.2014.0060

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Renaming ductal carcinoma in situ: would removing "carcinoma" reduce overtreatment?导管原位癌更名：去除“癌”字会减少过度治疗吗？

J Natl Compr Canc Netw. 2014 Apr;12(4):599-602. doi: 10.6004/jnccn.2014.0060.

2

[Ductal carcinoma in situ: current anatomo-pathologic data].[导管原位癌：当前解剖病理学数据]

Rev Med Suisse Romande. 2003 May;123(5):295-8.

3

The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.乳腺原位癌（DCIS）和非典型导管增生（ADH）等乳腺浸润前疾病的诊断与管理——当前定义和分类

Breast Cancer Res. 2003;5(5):254-7. doi: 10.1186/bcr623. Epub 2003 Jul 29.

4

Overcoming Barriers in Ductal Carcinoma In Situ Management: From Overtreatment to Optimal Treatment.克服导管原位癌治疗中的障碍：从过度治疗到优化治疗。

J Clin Oncol. 2022 Jan 20;40(3):225-230. doi: 10.1200/JCO.21.01674. Epub 2021 Nov 23.

5

Ductal carcinoma in situ of the breast.

Hum Pathol. 1998 Nov;29(11):1329-32. doi: 10.1016/s0046-8177(98)90269-6.

6

The diagnosis and management of pre-invasive breast disease--current challenges, future hopes.乳腺疾病癌前病变的诊断与管理——当前挑战与未来希望

Breast Cancer Res. 2003;5(5):248-9. doi: 10.1186/bcr641. Epub 2003 Jul 28.

7

Use of the Van Nuys Ductal Carcinoma In Situ classification.使用范奈斯导管原位癌分类法。

Am J Surg Pathol. 2001 Apr;25(4):543-5. doi: 10.1097/00000478-200104000-00022.

8

Breast pathology: rationale for adopting the ductal intraepithelial neoplasia (DIN) classification.乳腺病理学：采用导管原位上皮内瘤变（DIN）分类的基本原理。

Nat Clin Pract Oncol. 2005 Mar;2(3):116-7. doi: 10.1038/ncponc0109.

9

Ductal carcinoma in situ of the breast.乳腺导管原位癌

N Engl J Med. 2004 Apr 1;350(14):1430-41. doi: 10.1056/NEJMra031301.

10

Ductal carcinoma in situ of the breast: is clinical follow-up necessary after treatment?乳腺导管原位癌：治疗后是否需要临床随访？

Clin Oncol (R Coll Radiol). 2013 Jul;25(7):445. doi: 10.1016/j.clon.2013.02.007. Epub 2013 Mar 15.

引用本文的文献

1

Risk perception of patients with ductal carcinoma (DCIS) of the breast and their healthcare practitioners: The importance of histopathological terminology, and the gaps in our knowledge.乳腺导管原位癌（DCIS）患者及其医护人员的风险认知：组织病理学术语的重要性以及我们知识上的差距。

Histol Histopathol. 2025 Mar;40(3):297-306. doi: 10.14670/HH-18-806. Epub 2024 Sep 3.

2

"Is it cancer or not?" A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ.“这是癌症吗？” 对导管原位癌诊断和治疗相关的幸存者关注点的定性探索。

Cancer. 2022 Apr 15;128(8):1676-1683. doi: 10.1002/cncr.34126. Epub 2022 Feb 22.